Generic Name: icatibant
Common side effects of Firazyr include: hematoma at injection site, injection site reaction, urticaria at injection site, bruising at injection site, burning sensation at injection site, erythema at injection site, irritation at injection site, pain at injection site, and swelling at injection site.  See below for a comprehensive list of adverse effects.
Applies to icatibant: subcutaneous solution
In addition to its needed effects, some unwanted effects may be caused by icatibant (the active ingredient contained in Firazyr). In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking icatibant:
Some of the side effects that can occur with icatibant may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to icatibant: subcutaneous solution
The most common adverse reactions were injection site reactions, pyrexia, transaminase increased, dizziness, and rash.[Ref]
Injection site reaction includes bruising, hematoma, burning, erythema, hypoesthesia, irritation, numbness, edema, pain, pressure sensation, pruritus, swelling, urticaria, or warmth at the site of injection.[Ref]
Very common (10% or more): Injection site reaction (97%)[Ref]
Common (1% to 10%): Rash, pruritus, erythemaUncommon (0.1% to 1%): Generalized urticaria[Ref]
Common (1% to 10%): Nasopharyngitis, nasal congestionUncommon (0.1% to 1%): Pharyngitis, asthma, cough[Ref]
Common (1% to 10%): Gastroenteritis, nauseaUncommon (0.1% to 1%): Vomiting[Ref]
Common (1% to 10%): Dizziness, headache[Ref]
Common (1% to 10%): PyrexiaUncommon (0.1% to 1%): Asthenia, fatigue, contusion[Ref]
Common (1% to 10%): Transaminase increasedUncommon (0.1% to 1%): Liver function test abnormal[Ref]
Common (1% to 10%): Prothrombin time prolonged[Ref]
Common (1% to 10%): Blood creatinine phosphokinase increased[Ref]
Uncommon (0.1% to 1%): Weight increased, blood glucose increased, hyperuricemia, hyperglycemia[Ref]
Uncommon (0.1% to 1%): Herpes zosterFrequency not reported: Anti-icatibant (the active ingredient contained in Firazyr) antibodies[Ref]
Uncommon (0.1% to 1%): Hot flush[Ref]
Uncommon (0.1% to 1%): Proteinuria[Ref]
Uncommon (0.1% to 1%): Muscle spasm[Ref]
1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
2. Cerner Multum,  Inc. "Australian Product Information." O 0
3. "Product Information. Firazyr (icatibant)." Shire US Inc, Florence, KY. 
Not all side effects for Firazyr may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Fever


Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site


Dizziness


Headache
nausea
rash

